Ward S, Gatwood J
University of Wisconsin-Madison School of Nursing 53792.
Cancer Nurs. 1994 Jun;17(3):200-6.
Cancer pain is not adequately managed, and patients' reluctance to report pain and to use analgesics contribute to this problem. The Barriers Questionnaire (BQ) assesses eight patient concerns about reporting pain and using analgesics. This study was designed to determine (a) whether such concerns differ for persons who have cancer versus those who do not, (b) whether the BQ has test-retest reliability, and (c) whether concerns are related to reticence in reporting pain and using analgesics. Two groups, 53 adults with cancer and 40 without, completed the BQ twice at a 1-week interval. The BQ has eight subscales (e.g., concerns about addiction) and a total scale score (alpha = 0.89). There were no differences between persons with and without cancer on BQ total or subscale scores. Test-retest reliability of the total scale was r = 0.90, whereas the subscales showed r = 0.60-0.81. At Time 1, 16% said they hesitated to report pain, and 12% hesitated to use analgesics; at Time 2, 15% hesitated to report pain, and 10% hesitated to use analgesics. At Time 2, those who hesitated to report pain had higher BQ total scores than those who did not hesitate to report it (p < 0.05). We discuss the results of this study with respect to patient and public education.
癌症疼痛未得到充分管理,患者不愿报告疼痛及使用镇痛药加剧了这一问题。障碍问卷(BQ)评估了患者对报告疼痛及使用镇痛药的八个担忧。本研究旨在确定:(a)患癌者与未患癌者的此类担忧是否存在差异;(b)BQ是否具有重测信度;(c)这些担忧是否与报告疼痛及使用镇痛药时的沉默寡言有关。两组,53名成年癌症患者和40名非癌症患者,间隔1周完成两次BQ。BQ有八个分量表(如对成瘾的担忧)和一个总量表得分(α = 0.89)。患癌者与未患癌者在BQ总量表或分量表得分上无差异。总量表的重测信度r = 0.90,而分量表的重测信度r = 0.60 - 0.81。在第一次测试时,16%的人表示他们在报告疼痛时犹豫不决,12%的人在使用镇痛药时犹豫不决;在第二次测试时,15%的人在报告疼痛时犹豫不决,10%的人在使用镇痛药时犹豫不决。在第二次测试时,那些在报告疼痛时犹豫不决的人的BQ总量表得分高于那些不犹豫的人(p < 0.05)。我们从患者和公众教育的角度讨论了本研究的结果。